Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac

A novel therapeutic vaccine for chronic hepatitis B (CHB) treatment comprising the recombinant hepatitis B surface (HBsAg) and nucleocapsid (HBcAg) antigens has been developed. Preclinical and clinical trials (CT) evidenced safety and immunogenicity in animal models as well as in phases I, II, and I...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández, Guillermo, L Sanchez, Ana, Jerez, Everardo, E Anillo, Luis, Freyre, Freya, A Aguiar, Jorge, Leon, Yamila, Cinza, Zurina, A Diaz, Pablo, Figueroa, Nelvis, Muzio, Verena, G Nieto, Gerardo, Lobaina, Yadira, Aguilar, Arístides, Penton, Eduardo, C Aguilar, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395482/
https://www.ncbi.nlm.nih.gov/pubmed/30828555
http://dx.doi.org/10.5005/jp-journals-10018-1279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395482/
https://www.ncbi.nlm.nih.gov/pubmed/30828555
http://dx.doi.org/10.5005/jp-journals-10018-1279

Ejemplares similares